- Home
- ETON vs BBCP Comparison
ETON vs BBCP Comparison
Compare ETON & BBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- BBCP
- Stock Information
- Founded
- ETON 2017
- BBCP 1983
- Country
- ETON United States
- BBCP United States
- Employees
- ETON N/A
- BBCP N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- BBCP Engineering & Construction
- Sector
- ETON Health Care
- BBCP Consumer Discretionary
- Exchange
- ETON Nasdaq
- BBCP Nasdaq
- Market Cap
- ETON 329.8M
- BBCP 302.4M
- IPO Year
- ETON 2018
- BBCP 2017
- Fundamental
- Price
- ETON $13.26
- BBCP $5.68
- Analyst Decision
- ETON Strong Buy
- BBCP Buy
- Analyst Count
- ETON 3
- BBCP 4
- Target Price
- ETON $27.67
- BBCP $7.83
- AVG Volume (30 Days)
- ETON 219.8K
- BBCP 196.2K
- Earning Date
- ETON 05-08-2025
- BBCP 03-11-2025
- Dividend Yield
- ETON N/A
- BBCP N/A
- EPS Growth
- ETON N/A
- BBCP N/A
- EPS
- ETON N/A
- BBCP 0.28
- Revenue
- ETON $39,011,000.00
- BBCP $414,608,000.00
- Revenue This Year
- ETON $92.33
- BBCP $1.64
- Revenue Next Year
- ETON $52.62
- BBCP $5.84
- P/E Ratio
- ETON N/A
- BBCP $19.98
- Revenue Growth
- ETON 23.29
- BBCP N/A
- 52 Week Low
- ETON $3.03
- BBCP $4.78
- 52 Week High
- ETON $18.41
- BBCP $9.68
- Technical
- Relative Strength Index (RSI)
- ETON 41.34
- BBCP 44.90
- Support Level
- ETON $12.24
- BBCP $5.04
- Resistance Level
- ETON $13.64
- BBCP $6.14
- Average True Range (ATR)
- ETON 0.95
- BBCP 0.28
- MACD
- ETON -0.14
- BBCP 0.07
- Stochastic Oscillator
- ETON 29.23
- BBCP 58.37
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About BBCP Concrete Pumping Holdings Inc.
Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators position it to deliver concrete placement solutions. The company's operating segment includes U.S. Concrete Pumping; U.K. Operations; U.S. Concrete Waste Management Services and Corporate. It generates maximum revenue from the U.S. Concrete Pumping segment. Geographically, it generates majority of the revenue from its business in United States.